Menopause Hormone Therapy (HRT) in Delano, CA

Bioidentical hormones in Delano: what it means

Behind the label "bioidentical hormone replacement therapy" is a plain idea: a hormone whose structure matches the body's own. Two hormones used in menopause care fit it exactly, estradiol and micronized progesterone. FDA-approved versions of both are sold by prescription at retail pharmacies.

Only 6 OB-GYNs list a primary practice address in Delano in the NPI registry. For 50,835 residents that is 11.8 per 100,000, under the US 17.8 and below California's 16.9. That is about 850 women aged 45 to 64 for each OB-GYN in the city, a ratio rather than a count of open appointments.

Supply stays thin beyond the city line: 6 OB-GYNs within 10 miles and 9 within 25, only 3.9 per 100,000 of the 230,129 people who live in that radius, under the US 17.8. Whether or not you have an OB-GYN, you can ask a physician licensed in California about menopause hormone therapy online from Delano, with no waiting room.

"BHRT" often means compounded hormones, a cream, a blend such as Bi-Est or a pellet that a pharmacy mixes for one prescription. They are not FDA-approved, which means the FDA cannot assure their safety or effectiveness. The FDA says it has no evidence that compounded "bioidentical hormones" are safe and effective, or more effective than FDA-approved hormone therapy. The National Academies, reviewing them for the FDA in 2020, called their wide use a public health concern.

For women in Delano, a physician licensed in California can prescribe estradiol (pill, patch, cream or vaginal) and progesterone when they fit your history. There are no pellets. The pharmacy that fills VevaMD prescriptions also compounds, so ask your physician whether yours is an FDA-approved product or compounded. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

A pellet clinic is a different model: it implants a hormone pellet under the skin during a visit, and compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG's guidance is to prefer FDA-approved menopause hormone therapy to compounded hormones.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11